{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:00:39Z","timestamp":1790438439308,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273320"],"award-info":[{"award-number":["82273320"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U25A6003"],"award-info":[{"award-number":["U25A6003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370974"],"award-info":[{"award-number":["82370974"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472686"],"award-info":[{"award-number":["82472686"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2019-I2M-5-004"],"award-info":[{"award-number":["2019-I2M-5-004"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.intimp.2026.117276","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:39:50Z","timestamp":1786649990000},"page":"117276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Microenvironmental TRIM21 suppresses antitumor immunity in OSCC"],"prefix":"10.1016","volume":"188","author":[{"given":"Yuting","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yansong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2026.117276_bb0005","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41368-023-00249-w","article-title":"Oral squamous cell carcinomas: state of the field and emerging directions","volume":"15","author":"Tan","year":"2023","journal-title":"Int. J. Oral Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.117276_bb0010","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","volume":"6","author":"Johnson","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"10212","key":"10.1016\/j.intimp.2026.117276_bb0015","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","article-title":"Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study","volume":"394","author":"Burtness","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.intimp.2026.117276_bb0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1056\/NEJMoa2415434","article-title":"Neoadjuvant and adjuvant pembrolizumab in locally advanced head and neck cancer","volume":"393","author":"Uppaluri","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.intimp.2026.117276_bb0025","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S1470-2045(24)00100-1","article-title":"Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial","volume":"25","author":"Machiels","year":"2024","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117276_bb0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41423-025-01371-x","article-title":"PA28\u03b3-containing tumor-derived exosomes promote T-cell dysfunction in head and neck squamous cell carcinoma","volume":"23","author":"Wang","year":"2026","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2026.117276_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.738473","article-title":"TRIM21\/Ro52 - roles in innate immunity and autoimmune disease","volume":"12","author":"Jones","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117276_bb0040","doi-asserted-by":"crossref","first-page":"1637451","DOI":"10.3389\/fcell.2025.1637451","article-title":"TRIM21: a multifaceted regulator in cancer","volume":"13","author":"Li","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2026.117276_bb0045","article-title":"The emerging roles of TRIM21 in coordinating cancer metabolism, immunity and cancer treatment","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117276_bb0050","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ymthe.2025.01.047","article-title":"Targeting the TRIM21-PD-1 axis potentiates immune checkpoint blockade and CAR-T cell therapy","volume":"33","author":"Shi","year":"2025","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2026.117276_bb0055","doi-asserted-by":"crossref","first-page":"eadd6626","DOI":"10.1126\/sciadv.add6626","article-title":"Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicity","volume":"9","author":"Fu","year":"2023","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.intimp.2026.117276_bb0060","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41467-023-36523-y","article-title":"TRIM21 inhibits irradiation-induced mitochondrial DNA release and impairs antitumour immunity in nasopharyngeal carcinoma tumour models","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117276_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105443","article-title":"TRIM21 - a potential novel therapeutic target in cancer","volume":"165","author":"Alomari","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.117276_bb0070","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41419-025-07383-9","article-title":"TRIM21-mediated PRMT1 degradation attenuates colorectal cancer malignant progression","volume":"16","author":"Cao","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2026.117276_bb0075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.canlet.2021.03.023","article-title":"Trim21-mediated HIF-1\u03b1 degradation attenuates aerobic glycolysis to inhibit renal cancer tumorigenesis and metastasis","volume":"508","author":"Chen","year":"2021","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.intimp.2026.117276_bb0080","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12964-025-02325-6","article-title":"TRIM21 functions as an oncogene in glioblastoma by transactivating FOSL1 and promoting the ubiquitination of p27","volume":"23","author":"Ramar","year":"2025","journal-title":"Cell Commun. Signal"},{"issue":"13","key":"10.1016\/j.intimp.2026.117276_bb0085","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.7150\/ijms.56614","article-title":"TRIM21 polymorphisms are associated with susceptibility and clinical status of Oral squamous cell carcinoma patients","volume":"18","author":"Chuang","year":"2021","journal-title":"Int. J. Med. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2026.117276_bb0090","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.immuni.2022.04.016","article-title":"Dendritic cells can prime anti-tumor CD8(+) T cell responses through major histocompatibility complex cross-dressing","volume":"55","author":"MacNabb","year":"2022","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.intimp.2026.117276_bb0095","first-page":"681","article-title":"PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer","volume":"1","author":"Oh","year":"2020","journal-title":"Nat. Can."},{"issue":"1","key":"10.1016\/j.intimp.2026.117276_bb0100","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1038\/s41467-020-18570-x","article-title":"PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade","volume":"11","author":"Peng","year":"2020","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.intimp.2026.117276_bb0105","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1084\/jem.20160801","article-title":"PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity","volume":"214","author":"Juneja","year":"2017","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.intimp.2026.117276_bb0110","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/ni.2548","article-title":"Intracellular antibody-bound pathogens stimulate immune signaling via the fc receptor TRIM21","volume":"14","author":"McEwan","year":"2013","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2026.117276_bb0115","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","article-title":"Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression","volume":"19","author":"Garcia-Diaz","year":"2017","journal-title":"Cell Rep."},{"issue":"12","key":"10.1016\/j.intimp.2026.117276_bb0120","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1111\/all.12501","article-title":"Differential activation of dendritic cells by toll-like receptors causes diverse differentiation of na\u00efve CD4+ T cells from allergic patients","volume":"69","author":"Deifl","year":"2014","journal-title":"Allergy"},{"issue":"7","key":"10.1016\/j.intimp.2026.117276_bb0125","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41419-024-06944-8","article-title":"Trim21-mediated CCT2 ubiquitination suppresses malignant progression and promotes CD4(+)T cell activation in breast cancer","volume":"15","author":"Chen","year":"2024","journal-title":"Cell Death Dis."},{"issue":"19","key":"10.1016\/j.intimp.2026.117276_bb0130","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.1038\/s44318-024-00201-6","article-title":"EPDR1 promotes PD-L1 expression and tumor immune evasion by inhibiting TRIM21-dependent ubiquitylation of IkappaB kinase-\u03b2","volume":"43","author":"Qian","year":"2024","journal-title":"EMBO J."},{"issue":"7","key":"10.1016\/j.intimp.2026.117276_bb0135","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.chembiol.2023.05.009","article-title":"TRIM21 is a druggable target for the treatment of metastatic colorectal cancer through ubiquitination and activation of MST2","volume":"30","author":"Liu","year":"2023","journal-title":"Cell Chem. Biol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926011227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926011227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:34:01Z","timestamp":1790436841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926011227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":27,"alternative-id":["S1567576926011227"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117276","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microenvironmental TRIM21 suppresses antitumor immunity in OSCC","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117276","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117276"}}